NARAMIG

This brand name is authorized in Australia, Brazil, Estonia, Finland, France, Germany, Israel, Lithuania, Netherlands, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug NARAMIG contains one active pharmaceutical ingredient (API):

1	Naratriptan UNII 10X8X4P12Z - NARATRIPTAN HYDROCHLORIDE
	Naratriptan has been shown to be a selective agonist for 5 hydroxytryptamine1 (5-HT1) receptors mediating vascular contraction. This receptor is found predominantly in intracranial (cerebral and dural) blood vessels. Naratriptan is indicated for the acute treatment of migraine attacks with or without aura.
	Read more about Naratriptan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NARAMIG Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CC02	Naratriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8298R, 9734H
BR	Câmara de Regulação do Mercado de Medicamentos	510605201111316, 510614050051703
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02465536, 08608801
EE	Ravimiamet	1036459, 1076790, 1076802
ES	Centro de información online de medicamentos de la AEMPS	61828
FI	Lääkealan turvallisuus- ja kehittämiskeskus	489963
FR	Base de données publique des médicaments	67586588
GB	Medicines & Healthcare Products Regulatory Agency	139356, 143217, 143218, 143219, 20113, 373616
IL	מִשְׂרַד הַבְּרִיאוּת	8161
LT	Valstybinė vaistų kontrolės tarnyba	1003095
NL	Z-Index G-Standaard, PRK	48534
PL	Rejestru Produktów Leczniczych	100123308
SG	Health Sciences Authority	09914P
ZA	Health Products Regulatory Authority	32/7.3/0463